Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the 'D-Kids' study protocol

被引:4
|
作者
Binks, Michael J. [1 ]
Bleakley, Amy S. [1 ]
Pizzutto, Susan J. [1 ]
Lamberth, Michelle [1 ,2 ]
Powell, Verity [1 ,2 ]
Nelson, Jane [1 ]
Kirby, Adrienne [3 ]
Morris, Peter S. [1 ,4 ]
Simon, David [2 ]
Mulholland, E. Kim [5 ,6 ]
Rathnayake, Geetha [7 ]
Leach, Amanda J. [1 ]
D'Antoine, Heather [1 ]
Licciardi, Paul, V [5 ,8 ]
Snelling, Tom [9 ,10 ]
Chang, Anne B. [1 ,11 ]
机构
[1] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Casuarina, NT, Australia
[2] Royal Darwin Hosp, Dept Obstet & Gynaecol, Tiwi, NT, Australia
[3] Univ Sydney CAR, Natl Hlth & Med Res Council, Clin Trials Ctr, Glebe, NSW, Australia
[4] Royal Darwin Hosp, Dept Paediat, Tiwi, NT, Australia
[5] Murdoch Childrens Res Inst, New Vaccines Res Grp, Parkville, Vic, Australia
[6] London Sch Hyg & Trop Med, Epidemiol & Publ Hlth, London, England
[7] Virtus Diagnost, Sydney, NSW, Australia
[8] Univ Melbourne VCCC, Dept Paediat, Parkville, Vic, Australia
[9] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia
[10] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia
[11] Queensland Univ Technol, Ctr Childrens Hlth Res, Brisbane, Qld, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Respiratory Infection; Bacterial Infection; Viral infection; Pneumonia; Infection Control; Innate Immunity; DRIED BLOOD SPOTS; NORTHERN-TERRITORY; NASOPHARYNGEAL CARRIAGE; INDIGENOUS CHILDREN; OTITIS-MEDIA; DOUBLE-BLIND; D DEFICIENCY; PREGNANCY; HEALTH; INFANTS;
D O I
10.1136/bmjresp-2023-001646
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
IntroductionGlobally, acute respiratory infections (ARIs) are a leading cause of childhood morbidity and mortality. While ARI-related mortality is low in Australia, First Nations infants are hospitalised with ARIs up to nine times more often than their non-First Nations counterparts. The gap is widest in the Northern Territory (NT) where rates of both acute and chronic respiratory infection are among the highest reported in the world. Vitamin D deficiency is common among NT First Nations neonates and associated with an increased risk of ARI hospitalisation. We hypothesise that perinatal vitamin D supplementation will reduce the risk of ARI in the first year of life. Methods and analysis'D-Kids' is a parallel (1:1), double-blind (allocation concealed), randomised placebo-controlled trial conducted among NT First Nations mother-infant pairs. Pregnant women and their babies (n=314) receive either vitamin D or placebo. Women receive 14 000 IU/week or placebo from 28 to 34 weeks gestation until birth and babies receive 4200 IU/week or placebo from birth until age 4 months. The primary outcome is the incidence of ARI episodes receiving medical attention in the first year of life. Secondary outcomes include circulating vitamin D level and nasal pathogen prevalence. Tertiary outcomes include infant immune cell phenotypes and challenge responses. Blood, nasal swabs, breast milk and saliva are collected longitudinally across four study visits: enrolment, birth, infant age 4 and 12 months. The sample size provides 90% power to detect a 27.5% relative reduction in new ARI episodes between groups. Ethics and disseminationThis trial is approved by the NT Human Research Ethics Committee (2018-3160). Study outcomes will be disseminated to participant families, communities, local policy-makers, the broader research and clinical community via written and oral reports, education workshops, peer-reviewed journals, national and international conferences.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Effects of communication training with the MAAS-Global-D instrument on the antibiotic prescribing for respiratory infections in primary care: study protocol of a randomised controlled trial
    Friederike Hammersen
    Katja Goetz
    Andreas Soennichsen
    Timo Emcke
    Jost Steinhaeuser
    Trials, 17
  • [42] Effects of communication training with the MAAS-Global-D instrument on the antibiotic prescribing for respiratory infections in primary care: study protocol of a randomised controlled trial
    Hammersen, Friederike
    Goetz, Katja
    Soennichsen, Andreas
    Emcke, Timo
    Steinhaeuser, Jost
    TRIALS, 2016, 17
  • [43] Calcium and vitamin D supplementation and/or periodontal therapy in the treatment of periodontitis among Brazilian pregnant women: protocol of a feasibility randomised controlled trial (the IMPROVE trial) (vol 5, 38, 2019)
    Cocate, Paula Guedes
    Kac, Gilberto
    Hieitmann, Berit Lilienthal
    Nadanovsky, Paulo
    da Veiga Soares Carvalho, Maria Claudia
    Benaim, Camila
    Schluessel, Michael Maia
    Trindade de Castro, Maria Beatriz
    Alves-Santos, Nadya Helena
    Baptista, Amanda Farnum
    Holick, Michael F.
    Mokhtar, Rana R.
    Bomfim, Alessandra Raymundo
    Adegboye, Amanda Rodrigues Amorim
    PILOT AND FEASIBILITY STUDIES, 2020, 6 (01)
  • [44] Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial
    Dzavakwa, Nyasha Veronica
    Chisenga, Molly
    McHugh, Grace
    Filteau, Suzanne
    Gregson, Celia Louise
    Kasonka, Lackson
    Kranzer, Katharina
    Banda-Mabuda, Hildah
    Mujuru, Hilda
    Redzo, Nicol
    Rowland-Jones, Sarah
    Schaible, Ulrich E.
    Simms, Victoria
    Ferrand, Rashida Abbas
    TRIALS, 2022, 23 (01)
  • [45] High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL)
    Mariani, Javier
    Tajer, Carlos
    Antonietti, Laura
    Inserra, Felipe
    Ferder, Leon
    Manucha, Walter
    TRIALS, 2021, 22 (01)
  • [46] High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL)
    Javier Mariani
    Carlos Tajer
    Laura Antonietti
    Felipe Inserra
    León Ferder
    Walter Manucha
    Trials, 22
  • [47] Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial
    Dzavakwa, Nyasha Veronica
    Chisenga, Molly
    McHugh, Grace
    Filteau, Suzanne
    Gregson, Celia Louise
    Kasonka, Lackson
    Kranzer, Katharina
    Mabuda, Hildah Banda
    Mujuru, Hilda
    Redzo, Nicol
    Rowland-Jones, Sarah
    Schaible, Ulrich E.
    Simms, Victoria
    Ferrand, Rashida Abbas
    TRIALS, 2024, 25 (01)
  • [48] Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
    Fiona Gaughran
    Dominic Stringer
    Michael Berk
    Shubulade Smith
    David Taylor
    Eromona Whiskey
    Sabine Landau
    Robin Murray
    Philip McGuire
    Poonam Gardner-Sood
    Gabriella Wojewodka
    Simone Ciufolini
    Harriet Jordan
    Jessie Clarke
    Lauren Allen
    Amir Krivoy
    Brendon Stubbs
    Philippa Lowe
    Maurice Arbuthnott
    Shanaya Rathod
    Andrew Boardman
    Mudasir Firdosi
    John J. McGrath
    Trials, 21
  • [49] Study protocol: design and rationale for an exploratory phase II randomized controlled trial to determine optimal vitamin D3 supplementation strategies for acute fracture healing
    Sheila Sprague
    Sofia Bzovsky
    Daniel Connelly
    Lehana Thabane
    Jonathan D. Adachi
    Gerard P. Slobogean
    Pilot and Feasibility Studies, 5
  • [50] Study protocol: design and rationale for an exploratory phase II randomized controlled trial to determine optimal vitamin D3 supplementation strategies for acute fracture healing
    Sprague, Sheila
    Bzovsky, Sofia
    Connelly, Daniel
    Thabane, Lehana
    Adachi, Jonathan D.
    Slobogean, Gerard P.
    PILOT AND FEASIBILITY STUDIES, 2019, 5 (01)